Read + Share
Cappagli V, Moriconi D, Bonadio AG, Giannese D, et al. Proteinuria is a late-onset adverse event in patients treated with cabozantinib. J Endocrinol Invest 2021;44:95-103.
PMID: 32363491
|
 |
|
Cappagli V, Moriconi D, Bonadio AG, Giannese D, et al. Proteinuria is a late-onset adverse event in patients treated with cabozantinib. J Endocrinol Invest 2021;44:95-103.
PMID: 32363491
|
|
|
|